PSA Screening Cuts Deaths By 20 Percent

Screening for prostate cancer can reduce deaths by 20 percent, according to the results of the European Randomized Study of Screening for Prostate Cancer. ERSPC is the world's largest prostate cancer screening study and provides robust, independently audited evidence, for the first time, of the effect of screening on prostate cancer mortality.

Read the whole article on Science Daily

More from Science Daily